1月30日晚间，又有两家上市公司被证监会立案。 宝馨科技(002514.SZ)1月30日公告称，公司及实控人马伟于近日收到证监会下发的《立案告知书》，因公司及马伟涉嫌信息披露违法违规，根据相关法律 法规，证监会决定对公司及马伟立案。 同时，宝馨科技还披露了业绩预告，2025年预计净亏损6000万元至1亿元，亏损金额有所缩减。 荃银高科表示，2025年度业绩出现亏损的主要原因是2025年度种子行业仍然面临着高库存、同质化严重的激烈市场竞争环境，同时受到自然灾害的影响， 导致公司种子销售价格下行、毛利率下降，同时基于谨慎性原则对应收款项、存货以及商誉等计提了充分的减值准备。 来源：综合上市公司公告 编辑：曹諵 校对：知晏 业绩变动原因主要是，报告期内营业收入同比略有下降，归属于上市公司股东的净利润同比大幅减亏。为应对智能制造板块原有定制设备配件业务订单持 续减少的影响，公司通过研发共享经济领域集成设备，开拓新客户和市场，在第四季度营业收入环比实现较大幅度增长且产品毛利稳定等。 荃银高科也同立案调查公告一同披露了2025年度业绩预报：2025年预计净亏损1.8亿元至2.7亿元。 本文仅供信息分享，不构成对任何人的任 ...

Investment Rating - The report assigns an "Accumulate" rating for the industry [3] Core Insights - The price of piglets follows a clear historical pattern, with expectations for continued price increases followed by a decline around May/June. A significant capacity reduction cycle is anticipated in 2026, primarily occurring in the second half of the year, while stock prices are expected to start rising in the first half [5][6] - The report emphasizes that piglet prices are influenced by production patterns, with December and January being peak slaughter months, leading to increased demand for piglets. Conversely, supply remains relatively stable, which can lead to price increases when demand surges [7] - The report highlights that piglet prices do not correlate with pig price expectations and cannot be used to predict pig prices. The annual variations in piglet prices are consistent, while pig prices fluctuate yearly, indicating a lack of direct relationship [7] - The report recommends focusing on the pig farming sector, predicting a significant capacity reduction cycle in 2026. It suggests that the first half of 2026 will resemble the first half of 2023, with losses in fat pigs but profits in piglets, leading to a smoother capacity reduction after the anticipated price drop in May/June [7] - Key companies to watch include Muyuan Foods, Wens Foodstuff Group, Tiankang Biological, Juxing Agriculture, and Shennong Group, as their valuations are currently at the bottom, with potential for stock price increases as the industry faces losses and clearer capacity reduction trends [7][8] Summary by Sections Historical Price Trends - Piglet prices exhibit a clear historical trend, typically bottoming out in December/January and peaking in May/June. The fluctuations are tied to seasonal production patterns and demand cycles [5][7] Production and Supply Dynamics - The report discusses the relationship between supply and demand, noting that while supply is stable, demand spikes during certain months can lead to price increases. The cyclical nature of pig farming is highlighted, with adjustments made to align production with demand [7] Investment Opportunities - The report identifies a significant capacity reduction cycle in the pig farming industry for 2026, suggesting that investors should focus on companies with strong fundamentals and current low valuations, as they are likely to benefit from the anticipated market changes [7][8]

1月30日晚间，又有两家上市公司被证监会立案。 荃银高科30日晚发布公告称，公司于2026年1月30日收到中国证监会下发的《立案告知书》，因公司涉嫌信息披露违法违规，中国证监会 决定对公司立案。 荃银高科表示，目前公司生产经营正常，立案调查不会对公司正常生产经营活动产生重大影响。公司将积极配合中国证监会的工作，严 格履行信息披露义务。 当晚，荃银高科发布2025年度业绩预报，2025年预计净亏损1.8亿元至2.7亿元。公司表示，2025年度业绩出现亏损的主要原因是2025年度 种子行业仍然面临着高库存、同质化严重的激烈市场竞争环境，同时受到自然灾害的影响，导致公司种子销售价格下行、毛利率下降， 同时基于谨慎性原则对应收款项、存货以及商誉等计提了充分的减值准备。 截至1月30日收盘，荃银高科日内涨4.3%，股价报10.42元/股，最新市值为99亿元，最新股东户数为3.8万户。 宝馨科技表示，立案调查期间，公司将积极配合调查，并严格履行信息披露义务。目前公司生产经营正常，未受影响。 当晚，宝馨科技发布业绩预报称，2025年预计净亏损6000万元至1亿元，亏损金额有所缩减。业绩变动原因主要是报告期内，营业收入同 比 ...

Group 1 - The China Securities Regulatory Commission (CSRC) has initiated investigations against two listed companies, Qianyuan High-Tech (荃银高科) and Baoxin Technology (宝馨科技), for suspected violations of information disclosure regulations [1][3] - Qianyuan High-Tech announced a projected net loss of 180 million to 270 million yuan for the year 2025, attributing the loss to high inventory levels, severe market competition, and natural disasters affecting seed sales prices and gross margins [2] - As of January 30, Qianyuan High-Tech's stock price increased by 4.3% to 10.42 yuan per share, with a market capitalization of 9.9 billion yuan and approximately 38,000 shareholders [3] Group 2 - Baoxin Technology also received a notice from the CSRC regarding an investigation into information disclosure violations, involving the company and its actual controller, Ma Wei [3] - Baoxin Technology projected a net loss of 60 million to 100 million yuan for 2025, with a reduction in the loss amount compared to previous forecasts, primarily due to a slight decline in revenue and a significant reduction in net profit loss [4] - As of January 30, Baoxin Technology's stock price decreased by 1.74% to 5.65 yuan per share, with a market capitalization of 4.1 billion yuan and approximately 73,000 shareholders [5]

登录新浪财经APP 搜索【信披】查看更多考评等级 1月30日，宝馨科技(002514.SZ)公告称，公司及公司实际控制人马伟于近日收到中国证监会下发的《立 案告知书》，因涉嫌信息披露违法违规，中国证监会决定对公司及公司实际控制人马伟立案。立案调查 期间，公司将积极配合调查，并严格履行信息披露义务。目前公司生产经营正常，未受影响。 业绩方面，宝馨科技公告，预计2025年度营业收入3.1亿元—3.3亿元，上年同期营业收入为3.36亿元。 预计2025年度归母净利润亏损6000万元—1亿元，上年同期亏损7.67亿元。 业绩方面，荃银高科公告称，预计2025年归属于上市公司股东的净利润为亏损1.80亿元至2.70亿元，上 年同期盈利9712.96万元。业绩变动主要原因系种子行业高库存、同质化竞争加剧及自然灾害影响，导 致销售价格下行、毛利率下降；同时基于谨慎性原则对应收款项、存货及商誉等计提减值准备。 截至1月30日收盘，宝馨科技跌1.74%，股价报5.65元/股。 此外，荃银高科(300087.SZ)公告称，公司于2026年1月30日收到中国证监会下发的《立案告知书》，因 公司涉嫌信息披露违法违规，中国证监会决定对 ...

荃银高科表示，目前，公司各项生产经营活动均正常开展，上述事项不会对公司的正常生产经营活动产 生重大影响。立案调查期间，公司将积极配合证监会的各项工作，严格按照相关规定及监管要求履行信 息披露义务。 北京商报讯（记者 王蔓蕾）1月30日晚间，荃银高科（300087）披露公告称，公司当日收到证监会下发 的《立案告知书》，因公司涉嫌信息披露违法违规，证监会决定对公司立案。 ...

1月30日，宝馨科技(002514.SZ)公告称，公司及公司实际控制人马伟于近日收到中国证监会下发的《立案 告知书》，因涉嫌信息披露违法违规，中国证监会决定对公司及公司实际控制人马伟立案。立案调查期 间，公司将积极配合调查，并严格履行信息披露义务。目前公司生产经营正常，未受影响。 两家公司被证监会立案调查。 业绩方面， 宝馨科技公告， 预计2025年度营业收入3.1亿元—3.3亿元，上年同期营业收入为 3.36亿元。预计2025年度归母净利润亏损6000万元—1亿元，上年同期亏损7.67亿元。 截至1月30日收盘， 宝馨科技跌1.74%，股价报5.65元/股。 此外，荃银高科(300087.SZ)公告称，公司于2026年1月30日收到中国证监会下发的《立案告知书》，因公 司涉嫌信息披露违法违规，中国证监会决定对公司立案。目前公司生产经营正常，立案调查不会对公司正 常生产经营活动产生重大影响。公司将积极配合中国证监会的工作，严格履行信息披露义务。 业绩方面， 荃银高科公告称，预计2025年归属于上市公司股东的净利润为亏损1.80亿元至2.70 亿元，上年同期盈利9712.96万元。业绩变动主要原因系种子行业高库 ...

Company Performance Forecasts - Zhongji Xuchuang expects a net profit of 9.8 billion to 11.8 billion yuan for 2025, representing a year-on-year increase of 89.50% to 128.17% due to strong demand for computing infrastructure and increased sales of high-speed optical modules [2] - Cambrian anticipates a net profit of 1.85 billion to 2.15 billion yuan for 2025, marking a turnaround from losses, driven by rising demand in the AI sector [3] - Xinye Technology forecasts a net profit of 9.4 billion to 9.9 billion yuan for 2025, reflecting a year-on-year growth of 231.24% to 248.86% due to increased investment in computing [4] - Aerospace Development expects a net loss of 1 billion to 1.65 billion yuan for 2025, although this represents an improvement from a loss of 1.673 billion yuan in the previous year [5] - Wentai Technology predicts a net loss of 9 billion to 13.5 billion yuan for 2025, impacted by significant investment losses and asset impairment [6] - China National Airlines anticipates a net loss of 1.3 billion to 1.9 billion yuan for 2025, compared to a loss of 237 million yuan in the previous year [8] - China Eastern Airlines expects a net loss of 1.3 billion to 1.8 billion yuan for 2025, despite an increase in passenger transport volume [9] - Huazhong Technology is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [10] Investment and Strategic Developments - Huayou Cobalt plans to collaborate on an integrated battery industry project in Indonesia, aiming to establish a production base for electric vehicle batteries [13] Shareholding Changes - BlueFocus Media's major shareholder plans to reduce holdings by up to 20 million shares due to personal financial needs [14] Other Company Updates - Yihualu expects a net loss of 2.176 billion to 2.791 billion yuan for 2025, with a projected negative net asset value, which may lead to a delisting risk warning [27] - Huayi Brothers anticipates a net loss of 289 million to 407 million yuan for 2025, with a potential negative net asset value that could trigger a delisting risk warning [28] - Kangtai Medical has obtained a medical device registration certificate for a non-invasive ventilator, enhancing its product line [29]

Core Viewpoint - The company, 荃银高科, has received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into alleged violations of information disclosure laws, but asserts that normal operations will not be significantly affected by this investigation [1]. Group 1 - The company received the "Notice of Investigation" from the CSRC on January 30, 2026, due to suspected violations of information disclosure regulations [1]. - The company confirms that its production and operations are normal and that the investigation will not have a major impact on its business activities [1]. - The company will actively cooperate with the CSRC and strictly fulfill its information disclosure obligations [1].

Group 1 - The company, QuanYin High-Tech, expects a net profit loss of 180 million to 270 million yuan for 2025, marking a shift from profit to loss year-on-year [1] - The primary reasons for the performance change include high inventory levels, severe market competition characterized by product homogeneity, and the impact of natural disasters, which have led to declining seed sales prices and reduced gross margins [1] - The company has made sufficient impairment provisions for receivables, inventory, and goodwill in accordance with accounting standards and policies, based on market and industry conditions and the principle of prudence [1]